Carvedilol 25mg tablets

Страна: Великобритания

Език: английски

Източник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активна съставка:

Carvedilol

Предлага се от:

Viatris UK Healthcare Ltd

АТС код:

C07AG02

INN (Международно Name):

Carvedilol

дозиране:

25mg

Лекарствена форма:

Oral tablet

Начин на приложение:

Oral

Клас:

No Controlled Drug Status

Вид предписание :

Valid as a prescribable product

Каталог на резюме:

BNF: 02040000; GTIN: 5016695000145

Данни за продукта

OBJECT 1
CARVEDILOL 25 MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 10-May-2017 | Generics UK
T/A Mylan
1. Name of the medicinal product
Carvedilol 25 mg Film-coated Tablets
2. Qualitative and quantitative composition
Each film-coated tablet contains 25 mg carvedilol
Excipient with known effect:
Each film-coated tablet contains 100 mg: lactose monohydrate
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablet
25 mg film-coated tablets: white, oval, scored on both sides and
marked "25" on one side.
The 25mg tablets can be divided into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
• Essential hypertension.
• Chronic stable angina pectoris
• Adjunctive treatment in moderate to severe stable heart failure.
4.2 Posology and method of administration
Carvedilol is available in 4 strengths: 3.125 mg, 6.25 mg, 12.5 mg and
25 mg
ESSENTIAL HYPERTENSION:
Carvedilol may be used for the treatment of hypertension alone or in
combination with other
antihypertensives, especially thiazide diuretics. Once daily dosing is
recommended, however the
recommended maximum single dose is 25 mg and the recommended maximum
daily dose is 50 mg.
Adults:
The recommended initial dose is 12.5 mg once a day for the first two
days. Thereafter, the treatment is
continued at the dose 25 mg/day. If necessary, the dose may be further
increased gradually at intervals of
at least two weeks.
Elderly:
The recommended initial dose in hypertension is 12.5 mg once a day,
which may also be sufficient for
continued treatment. However, if the therapeutic response is
inadequate at this dose, the dose may be
further increased gradually at intervals of at least two weeks.
CHRONIC STABLE ANGINA PECTORIS
Adults:
The recommended initial dose is 12.5 mg twice daily for two days.
Thereafter, the treatment is continued
at the dose 25 mg twice daily. If necessary, the dose may be further
increased gradually at intervals of at
least two weeks. The recommended maximum daily dose is 100 mg in